These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

785 related items for PubMed ID: 26992012

  • 1. Left Ventricular Global Longitudinal Strain in HER-2 + Breast Cancer Patients Treated with Anthracyclines and Trastuzumab Who Develop Cardiotoxicity Is Associated with Subsequent Recovery of Left Ventricular Ejection Fraction.
    Fei HW, Ali MT, Tan TC, Cheng KH, Salama L, Hua L, Zeng X, Halpern EF, Taghian A, MacDonald SM, Scherrer-Crosbie M.
    Echocardiography; 2016 Apr; 33(4):519-26. PubMed ID: 26992012
    [Abstract] [Full Text] [Related]

  • 2. Two-dimensional speckle tracking echocardiography predicts early subclinical cardiotoxicity associated with anthracycline-trastuzumab chemotherapy in patients with breast cancer.
    Arciniegas Calle MC, Sandhu NP, Xia H, Cha SS, Pellikka PA, Ye Z, Herrmann J, Villarraga HR.
    BMC Cancer; 2018 Oct 25; 18(1):1037. PubMed ID: 30359235
    [Abstract] [Full Text] [Related]

  • 3. Early diastolic strain rate measurements by cardiac MRI in breast cancer patients treated with trastuzumab: a longitudinal study.
    Gong IY, Ong G, Brezden-Masley C, Dhir V, Deva DP, Chan KKW, Graham JJ, Chow CM, Thavendiranathan P, Dai D, Ng MY, Barfett JJ, Connelly KA, Yan AT.
    Int J Cardiovasc Imaging; 2019 Apr 25; 35(4):653-662. PubMed ID: 30390170
    [Abstract] [Full Text] [Related]

  • 4. Time Trends of Left Ventricular Ejection Fraction and Myocardial Deformation Indices in a Cohort of Women with Breast Cancer Treated with Anthracyclines, Taxanes, and Trastuzumab.
    Tan TC, Bouras S, Sawaya H, Sebag IA, Cohen V, Picard MH, Passeri J, Kuter I, Scherrer-Crosbie M.
    J Am Soc Echocardiogr; 2015 May 25; 28(5):509-14. PubMed ID: 25772019
    [Abstract] [Full Text] [Related]

  • 5. Left ventricular systolic function in HER2/neu negative breast cancer patients treated with anthracycline chemotherapy: a comparative analysis of left ventricular ejection fraction and myocardial strain imaging over 12 months.
    Stoodley PW, Richards DA, Boyd A, Hui R, Harnett PR, Meikle SR, Byth K, Stuart K, Clarke JL, Thomas L.
    Eur J Cancer; 2013 Nov 25; 49(16):3396-403. PubMed ID: 23937961
    [Abstract] [Full Text] [Related]

  • 6. Reliability of Left Ventricular Ejection Fraction from Three-Dimensional Echocardiography for Cardiotoxicity Onset Detection in Patients with Breast Cancer.
    Lorenzini C, Lamberti C, Aquilina M, Rocca A, Cortesi P, Corsi C.
    J Am Soc Echocardiogr; 2017 Nov 25; 30(11):1103-1110. PubMed ID: 28822666
    [Abstract] [Full Text] [Related]

  • 7. Single Versus Standard Multiview Assessment of Global Longitudinal Strain for the Diagnosis of Cardiotoxicity During Cancer Therapy.
    Thavendiranathan P, Negishi T, Coté MA, Penicka M, Massey R, Cho GY, Hristova K, Vinereanu D, Popescu BA, Izumo M, Negishi K, Marwick TH, SUCCOUR Investigators.
    JACC Cardiovasc Imaging; 2018 Aug 25; 11(8):1109-1118. PubMed ID: 29778856
    [Abstract] [Full Text] [Related]

  • 8. Anthracyclines induce early changes in left ventricular systolic and diastolic function: A single centre study.
    Boyd A, Stoodley P, Richards D, Hui R, Harnett P, Vo K, Marwick T, Thomas L.
    PLoS One; 2017 Aug 25; 12(4):e0175544. PubMed ID: 28407011
    [Abstract] [Full Text] [Related]

  • 9. Comprehensive Assessment of Changes in Left Ventricular Diastolic Function With Contemporary Breast Cancer Therapy.
    Upshaw JN, Finkelman B, Hubbard RA, Smith AM, Narayan HK, Arndt L, Domchek S, DeMichele A, Fox K, Shah P, Clark A, Bradbury A, Matro J, Adusumalli S, Carver JR, Ky B.
    JACC Cardiovasc Imaging; 2020 Jan 25; 13(1 Pt 2):198-210. PubMed ID: 31542526
    [Abstract] [Full Text] [Related]

  • 10. Echocardiographic parameters of left ventricular size and function as predictors of symptomatic heart failure in patients with a left ventricular ejection fraction of 50-59% treated with anthracyclines.
    Mousavi N, Tan TC, Ali M, Halpern EF, Wang L, Scherrer-Crosbie M.
    Eur Heart J Cardiovasc Imaging; 2015 Sep 25; 16(9):977-84. PubMed ID: 25925220
    [Abstract] [Full Text] [Related]

  • 11. Cardiac Outcomes of Patients Receiving Adjuvant Weekly Paclitaxel and Trastuzumab for Node-Negative, ERBB2-Positive Breast Cancer.
    Dang C, Guo H, Najita J, Yardley D, Marcom K, Albain K, Rugo H, Miller K, Ellis M, Shapira I, Wolff AC, Carey LA, Moy B, Groarke J, Moslehi J, Krop I, Burstein HJ, Hudis C, Winer EP, Tolaney SM.
    JAMA Oncol; 2016 Jan 25; 2(1):29-36. PubMed ID: 26539793
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A Prospective Study About Trastuzumab-induced Cardiotoxicity in HER2-positive Breast Cancer.
    Ben Kridis W, Sghaier S, Charfeddine S, Toumi N, Daoud J, Kammoun S, Khanfir A.
    Am J Clin Oncol; 2020 Jul 25; 43(7):510-516. PubMed ID: 32304433
    [Abstract] [Full Text] [Related]

  • 17. Serial Cardiovascular Magnetic Resonance Strain Measurements to Identify Cardiotoxicity in Breast Cancer: Comparison With Echocardiography.
    Houbois CP, Nolan M, Somerset E, Shalmon T, Esmaeilzadeh M, Lamacie MM, Amir E, Brezden-Masley C, Koch CA, Thevakumaran Y, Yan AT, Marwick TH, Wintersperger BJ, Thavendiranathan P.
    JACC Cardiovasc Imaging; 2021 May 25; 14(5):962-974. PubMed ID: 33248962
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Evaluation of Trastuzumab-induced early cardiac dysfunction using two-dimensional Strain Echocardiography.
    Emren SV, Tuluce SY, Levent F, Tuluce K, Kalkan T, Yildiz Y, Alacacioğlu A, Kucukzeybek Y, Akyol M, Salman T.
    Med Ultrason; 2015 Dec 25; 17(4):496-502. PubMed ID: 26649345
    [Abstract] [Full Text] [Related]

  • 20. Continuous Trastuzumab Therapy in Breast Cancer Patients With Asymptomatic Left Ventricular Dysfunction.
    Yu AF, Yadav NU, Eaton AA, Lung BY, Thaler HT, Liu JE, Hudis CA, Dang CT, Steingart RM.
    Oncologist; 2015 Oct 25; 20(10):1105-10. PubMed ID: 26240135
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 40.